Security readout for executives and security teams
Plain-English summary
A flaw in Azure DevOps Server could let a low-privileged, network-connected attacker execute commands on the server. Successful exploitation could expose confidential data, alter repositories or build processes, and disrupt service. Exploitation is rated difficult, but the potential business impact is substantial.
Executive priority
Prioritize remediation in the next high-severity patch cycle, accelerating internet-reachable or sensitive development environments. Compromise could affect source code, build integrity, credentials, and operational availability. Require owners to verify actual build exposure because the supplied affected-version entries are not sufficiently clear for definitive scoping.
Technical view
CVE-2024-20667 is a network-reachable command-injection weakness (CWE-77) requiring low privileges, no user interaction, and high attack complexity. CVSS 3.1 is 7.5, with high confidentiality, integrity, and availability impacts. The supplied data identifies Azure DevOps Server entries but does not explain the vulnerable component or attack conditions.
Likely exposure
Potential exposure is limited to Azure DevOps Server deployments matching the source-listed version entries. Risk is greater where the server is reachable by untrusted networks or broadly provisioned authenticated users. The supplied version data is ambiguous, so administrators should confirm affected builds directly with Microsoft rather than relying solely on these entries.
Exploitation context
The supplied record does not establish active exploitation, and the CVE is not listed as KEV in the bundle. Its vector marks exploit maturity as unproven and remediation as an official fix. Exploitation requires low privileges and high complexity, reducing likelihood but not the severe potential impact.
Researcher notes
The available evidence supports CWE-77 and the CVSS characteristics but provides no vulnerable endpoint, component, exploitation mechanism, indicators, or confirmed attacks. The listed affected entries appear inconsistent or incomplete, including generic and date-like versions. Treat precise version mapping as unresolved until confirmed through Microsoft's advisory.
Mitigation direction
- Review Microsoft's CVE advisory and apply the applicable official Azure DevOps Server update.
- Restrict server access to trusted networks and authenticated users while remediation is pending.
- Review and reduce unnecessary Azure DevOps accounts and privileges.
- Back up critical repositories and configuration before applying updates.
Validation and detection
- Inventory Azure DevOps Server editions, versions, and installed update levels.
- Compare each deployed build against Microsoft's current CVE advisory.
- Confirm the applicable security update installed successfully on every server.
- Review server and authentication logs for unusual command execution or low-privilege account activity.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-77: Command execution behavior lookup
Command injection weaknesses can lead defenders to review execution techniques and command interpreter telemetry. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupExecution behavior lookup
The CVE wording references code or command execution, so execution technique review may help defensive triage. This is a Glexia inferred lookup path, not an official MITRE, ATT&CK, or CVE Program mapping.
Open ATT&CK lookupCVE-2024-20667 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- High
- CVSS
- 7.5 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H/E:U/RL:O/RC:C
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
SSVC decision data
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H/E:U/RL:O/RC:C1.65.9microsoftVulnerability scoring details
Base CVSS 3.1 score
7.5HighVector: CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H/E:U/RL:O/RC:C
Vulnerability timeline
Timeline events are normalized from CVE metadata, CNA source timelines, ADP timelines, and KEV metadata when present.
- CVE reservedCVE Program
The CVE ID was reserved by the assigning CNA.
- CVE publishedCVE Program
The CVE record was published.
- CVE updatedCVE Program
The CVE record metadata indicates this as the latest update time.
ADP provider summaries
Source materials
- CVE List V5 sourceCVE List V5
- Azure DevOps Server Remote Code Execution VulnerabilityCVE reference, microsoft · vendor-advisory, patch
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Improper Neutralization of Special Elements used in a Command ('Command Injection')
Improper Neutralization of Special Elements used in a Command ('Command Injection') represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.